Form 990 for tax year 2024

Totals

Total revenue

$1,417,189

Total expenses

$1,249,916

Contributions and grants received

$1,417,189

Grants paid

$0

Program service revenue

$0

Investment income

$0

Other revenue

$0

Total assets, end of year

$593,097

Total liabilities, end of year

$415,470

Net assets or fund balances, end of year

$177,627

Program services expenses (Part IX)

$1,216,276

Management and general expenses

$33,640

Fundraising expenses

$0

Program service expenses (Part III)

$1,216,276

Program services were 97.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Mission and programs · 2024

• COG RESEARCH FOUNDATION, LLC PROVIDES ADMINISTRATIVE, AS WELL AS STATISTICAL AND DATA MANAGEMENT SUPPORT FOR THE CHILDREN'S ONCOLOGY GROUP (COG). THE COG, A CLINICAL TRIALS GROUP SUPPORTED BY THE NATIONAL CANCER INSTITUTE, IS THE WORLD'S LARGEST ORGANIZATION DEVOTED EXCLUSIVELY TO CHILDHOOD AND ADOLESCENT CANCER RESEARCH. COG BRINGS TOGETHER MORE THAN 10,000 EXPERTS IN CHILDHOOD CANCER AT MORE THAN 200 INSTITUTIONS. THEY SUPPORT CLINICAL RESEARCH TRIALS THAT STUDY AND DETERMINE THE UNDERLYING BIOLOGY OF CHILDHOOD CANCERS, EMERGING TREATMENTS, SUPPORTIVE CARE, AND SURVIVORSHIP, AND CARE FOR 80-90% OF THE 13,500 CHILDREN AND ADOLESCENTS DIAGNOSED WITH CANCER EACH YEAR.COG IS STRUCTURED TO MAXIMIZE EFFICIENCY, PROMOTE COLLABORATION, AND RETAIN THE FLEXIBILITY TO FOCUS RESOURCES ON THE MOST PROMISING SCIENTIFIC ADVANCES. EXTENSIVE COLLABORATION AND INTEGRATION ARE FOUND THROUGHOUT COG'S ORGANIZATION. THE CHILDREN'S ONCOLOGY GROUP HAS OVER 50 ACTIVE CLINICAL TRIALS OPEN AT ANY GIVEN TIME. THESE TRIALS INCLUDE FRONT-LINE TREATMENT FOR MANY TYPES OF CHILDHOOD CANCERS, STUDIES AIMED AT DETERMINING THE UNDERLYING BIOLOGY OF THESE DISEASES, AND TRIALS INVOLVING NEW AND EMERGING TREATMENTS, SUPPORTIVE CARE, AND SURVIVORSHIP. THE CHILDREN'S ONCOLOGY GROUP RESEARCH HAS TURNED CHILDREN'S CANCER FROM A VIRTUALLY INCURABLE DISEASE 50 YEARS AGO TO ONE WITH A COMBINED 5-YEAR SURVIVAL RATE OF 86% TODAY. OUR GOAL IS TO CURE ALL CHILDREN AND ADOLESCENTS WITH CANCER, REDUCE THE SHORT AND LONG-TERM COMPLICATIONS OF CANCER TREATMENTS, AND DETERMINE THE CAUSES AND FIND WAYS TO PREVENT CHILDHOOD CANCER.

  Expenses $1,216,276

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

No itemized grants to organizations on this return.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

• THE CHILDREN'S ONCOLOGY GROUP FOUNDATION INC

  501(C)(3) · RAISE RESOURCES TO SUPPORT THE RESEARCH OF THE CHILDREN'S ONCOLOGY GROUP · PA

Provenance

Return type

form_990

Tax year

2024

Filed

10 April 2026

IRS schema version

2024v5.5

Source object

202621039349301412

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.